hydromorphone has been researched along with SC Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, MC; Dampier, CD; Hsu, L; Keefer, J; Kim, HY; Krishnamurti, L; Mack, AK; McClish, D; McKinlay, SM; Miller, ST; Minniti, CP; Osunkwo, I; Seaman, P; Smith, WR; Telen, MJ; Wager, CG; Weiner, DL | 1 |
1 trial(s) available for hydromorphone and SC Disease
Article | Year |
---|---|
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.
Topics: Adolescent; Adult; Age Factors; Analgesia, Patient-Controlled; Analgesics, Opioid; Child; Dose-Response Relationship, Drug; Early Termination of Clinical Trials; Female; Hemoglobin SC Disease; Humans; Hydromorphone; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Morphine; Pain; Vascular Diseases; Young Adult | 2011 |